Versigent to Issue Quarterly Dividend of $0.13 (NYSE:VGNT)

Versigent (NYSE:VGNTGet Free Report) announced a quarterly dividend on Monday, August 3rd. Stockholders of record on Friday, September 4th will be given a dividend of 0.13 per share on Friday, September 18th. This represents a c) dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, September 4th.

Versigent Price Performance

VGNT stock traded up $3.77 during trading on Tuesday, hitting $45.81. 2,472,548 shares of the company traded hands, compared to its average volume of 2,090,241. The stock has a 50-day moving average of $43.28. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88.

Versigent (NYSE:VGNTGet Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34.

Analyst Ratings Changes

Several research analysts recently commented on VGNT shares. Wall Street Zen raised shares of Versigent to a “hold” rating in a research note on Saturday, April 18th. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. Argus set a $50.00 price target on shares of Versigent in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft upgraded shares of Versigent from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research report on Tuesday, July 7th. Finally, Wolfe Research began coverage on shares of Versigent in a research note on Thursday, April 30th. They set an “outperform” rating and a $53.00 price objective for the company. Three analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Versigent presently has an average rating of “Buy” and an average target price of $49.67.

Check Out Our Latest Research Report on VGNT

See Also

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.